1979
DOI: 10.1021/bi00573a025
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and identification of 24,25-dihydroxy vitamin D2 by use of the perfused rat kidney

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
7
0
1

Year Published

1981
1981
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(13 citation statements)
references
References 16 publications
(24 reference statements)
5
7
0
1
Order By: Relevance
“…has been reported to be metabolized to 24,25(OH) 2 D2 and 24,25,26(OH) 3 D2 by perfused rat kidneys [212,213]. It has also been shown to be metabolized to 24R, 25,28(OH) 3 D2 and 24S,25,28(OH) 3 D2 by perfused rat kidneys and rat kidney homogenates with evidence for further metabolism to water-soluble products [214], presumably by CYP24A1.…”
Section: (Oh)d2mentioning
confidence: 98%
“…has been reported to be metabolized to 24,25(OH) 2 D2 and 24,25,26(OH) 3 D2 by perfused rat kidneys [212,213]. It has also been shown to be metabolized to 24R, 25,28(OH) 3 D2 and 24S,25,28(OH) 3 D2 by perfused rat kidneys and rat kidney homogenates with evidence for further metabolism to water-soluble products [214], presumably by CYP24A1.…”
Section: (Oh)d2mentioning
confidence: 98%
“…Doxercalciferol ( 21 ), developed by Bone Care International, was launched in 1999 with the sales name of Hectorol for the treatment of 2HPT in the US. Although doxercalciferol ( 21 ) is a prodrug of active vitamin D 2 (1α,25-dihydroxyvitamin D 2 22 ) ( Scheme 4 ) and, like calcitriol (1α,25-dihydroxyvitamin D 3 ), which is the counterpart of alfacalcidol, must be activated in vivo , the mechanism for the biological action of doxercalciferol is much less well understood than for alfacalcidol [ 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. The results of a trial with doxercalciferol in renal failure patients with moderate to severe 2HPT (intact PTH greater than 400 pg/mL) were reported [ 33 ].…”
Section: Doxercalciferolmentioning
confidence: 99%
“…Because of the structural differences in the side chains of vitamins D2 and D3, some of the aforementioned chemical alterations occurring on the side chain of 1,25-(OH)2D3 may not occur on the side chain of l,25(OH)2D2 especially with respect to C-23 hydroxylation, C-24 ketonization, and C-23:C-26 lactonization. As far as C-24 hydroxylation is concerned, it has been already well established that vitamin D2 and 25(OH)D2 undergo C-24 hydroxylation to form 24(OH)D2 and 24,25(OH)2D2, respectively (Jones et al, 1979(Jones et al, , 1980. Therefore, l,25(OH)2D2 may also undergo C-24 hydroxylation to form l,24,25(OH)3D2.…”
Section: Discussionmentioning
confidence: 99%